Rapid Ischemic Preconditioning with a Short Reperfusion Time Prevents Delayed Paraplegia in a Rabbit Model
Background: Surgery for thoracic and thoracoabdominal aortic aneurysms can be complicated by a significant incidence of neurogenic deficits due to spinal cord ischemia. In this study, we investigated whether ischemic preconditioning (IPC) improves neurologic outcome in a rabbit model.
Methods: Forty rabbits underwent infrarenal aortic occlusion. The IPC group (n = 20) had 10 minutes of aortic occlusion to induce spinal cord ischemia, 40 minutes of reperfusion, and 30 minutes of ischemia, whereas the control group (n = 20) had only 30 minutes of ischemia. Tarlov scoring (0, paraplegia; 4, normal) was used to evaluate neurologic functions 7 days later, and spinal cord segments (L4-L6) were stained with hematoxylin and eosin for histologic evaluation.
Results: Complete paraplegia (grade 0) occurred in 15 (75%) of the 20 control animals, whereas in the IPC group, 13 (65%) of 20 animals were completely normal (grade 4) (P < .05).
Conclusion: IPC is beneficial for protecting against neurologic damage after transient aortic occlusion in a rabbit model; however, the protective mechanisms are not clear.
Abraham VS, Swain JA, Forgash AJ, Williams BL, Musulin MM. 2000. Ischemic preconditioning protects against paraplegia after transient aortic occlusion in the rat. Ann Thorac Surg 69:475-9.nBarone FC, White RF, Spera PA 1998. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29:1937-51.nBasaran M, Kafali E, Sayin O 2005. Heat stress increases the effectiveness of early ischemic preconditioning in spinal cord protection. Eur J Cardiothorac Surg 28:467-72.nCarlson DE, Karp RB, Kouchoukos NT. 1983. Surgical treatment of aneurysms of the descending thoracic aorta: an analysis of 85 patients. Ann Thorac Surg 35:58-69.nCassada DC, Gangemi JJ, Rieger JM 2001. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann Thorac Surg 72:1245-50.nCrawford ES, Crawford JL, Safi HJ, Coselli JS, Hess KR, Books B. 1986. Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 3:389-404.nCrawford ES, Waler HS, Saleh SA, Normann NA. 1981. Graft replacement of aneurysm in descending thoracic aorta: results without shunting. Surgery 89:73-85.nFan T, Wang CC, Wang FM 1999. Experimental study of the protection of ischemic preconditioning to spinal cord ischemia. Surg Neurol 52:299-305.nGarnier A, Rossi A, Lavanchy N. 1996. Importance of the early alterations of energy metabolism in the induction and the disappearance of ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 28:1671-82.nHeurteaux C, Lauritzen I, Widmann C, Lazdunski M. 1995. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 92:4666-70.nKakimoto M, Kawaguchi M, Sakamoto T 2003. Evaluation of rapid ischemic preconditioning in a rabbit model of spinal cord ischemia. Anesthesiology 99:1112-7.nKannellopoulos GK, Kato H, Wu Y 1997. Neuronal cell death in the ischemic spinal cord: the effect of methylprednisolone. Ann Thorac Surg 64:1279-85.nKato H, Liu Y, Araki T, Kogure K. 1991. Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res 553:238-42.nMatsuyama K, Chiba Y, Ihaya A, Kimura T, Tanigawa N, Muraoka R. 1997. Effect of spinal cord preconditioning on paraplegia during crossclamping of the thoracic aorta. Ann Thorac Surg 63:1315-20.nMotoyoshi N, Sakurai M, Hayashi T 2001. Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein. J Thorac Cardiovasc Surg 122:351-7.nMunyao N, Kaste M, Lindsberg PJ. 1998. Tolerization against loss of neuronal function after ischemia-reperfusion injury. Neuroreport 9:321-5.nMurry CE, Jennings RB, Reimer KA. 1986. Preconditioning with ischemia: a delay in lethal cell injury in ischemic myocardium. Circulation 74:1124-36.nNakamura M, Nakakimura K, Matsumoto M, Sakabe T. 2002. Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonists. J Cereb Blood Flow Metab 22:161-70.nPerez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ. 1997. Rapid ischemic preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab 17:175-82.nPontius RG, Brockman HT, Hardy EG, Cooley DA, DeBakey ME. 1954. The use of hypothermia on the prevention of paraplegia following temporary aortic occlusion: experimental observations. Surgery 36:33-8.nRoss SD, Kern JA, Gangemi JJ 2000. Hypothermic retrograde venous perfusion with adenosine cools the spinal cord and reduces the risk of paraplegia after thoracic aortic clamping. J Thorac Cardiovasc Surg 119:588-95.nSafi HJ, Hess KR, Randel M 1996. Cerebrospinal fluid drainage and distal aortic perfusion: reducing neurologic complications in repair of thoracoabdominal aortic aneurysm types I and II. J Vasc Surg 23:223-9.nSakurai M, Hayashi T, Abe K, Aoki M, Sadahiro M, Tabayashi K. 1998. Enhancement of heat shock protein expression after transient ischemia in the preconditioned spinal cord of rabbits. J Vasc Surg 1998;27:720-5.nSvensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. 1993. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 17:357-70.nSvensson LG, Rickards E, Coull A, Rogers G, Flimmel CJ, Hinder RA. 1986. Relationship of spinal blood flow to vascular anatomy during thoracic aortic cross-clamping and shunting. J Thorac Cardiovasc Surg 91:71-8.nSymbas PN, Pfaender LM, Drucker MH, Lester JL, Gravanis MB, Zacharopoulos L. 1983. Cross-clamping of descending aorta: hemodynamic and neurohumoral effects. J Thorac Cardiovasc Surg 85:300-5.nWan IYP, Angelini GD, Bryan AJ, Ryder I, Underwood MJ. 2001. Prevention of spinal cord ischemia during descending thoracic and thoracoabdominal aortic surgery. Eur J Cardiothorac Surg 19:203-13.nZvara DA, Colonna DM, Deal DD, Vernon JC, Gowda M, Lundell JC. 1999. Ischemic preconditioning reduces neurologic injury in a rat model of spinal cord ischemia. Ann Thorac Surg 68:874-80.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).